Login to Your Account



Speedel, Novartis Gain FDA Approval Of Hypertension Drug

By Aaron Lorenzo


Wednesday, March 7, 2007
The FDA approved a new drug for high blood pressure, Tekturna (aliskiren), a first-in-class product partnered between Speedel Group and Novartis AG. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription